NO20030926D0 - Process for the preparation of hydrates of olanzapine and their conversion to crystalline forms of olanzapine - Google Patents

Process for the preparation of hydrates of olanzapine and their conversion to crystalline forms of olanzapine

Info

Publication number
NO20030926D0
NO20030926D0 NO20030926A NO20030926A NO20030926D0 NO 20030926 D0 NO20030926 D0 NO 20030926D0 NO 20030926 A NO20030926 A NO 20030926A NO 20030926 A NO20030926 A NO 20030926A NO 20030926 D0 NO20030926 D0 NO 20030926D0
Authority
NO
Norway
Prior art keywords
olanzapine
hydrates
conversion
preparation
crystalline forms
Prior art date
Application number
NO20030926A
Other languages
Norwegian (no)
Other versions
NO20030926L (en
Inventor
Robert Koprowski
Original Assignee
Reddys Lab Ltd Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Ltd Dr filed Critical Reddys Lab Ltd Dr
Publication of NO20030926D0 publication Critical patent/NO20030926D0/en
Publication of NO20030926L publication Critical patent/NO20030926L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20030926A 2000-08-31 2003-02-27 Process for the preparation of hydrates of olanzapine and their conversion to crystalline forms of olanzapine NO20030926L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN709CH2000 2000-08-31
IN711CH2000 2000-08-31
PCT/US2001/007258 WO2002018390A1 (en) 2000-08-31 2001-03-07 Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine

Publications (2)

Publication Number Publication Date
NO20030926D0 true NO20030926D0 (en) 2003-02-27
NO20030926L NO20030926L (en) 2003-04-24

Family

ID=26324874

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030926A NO20030926L (en) 2000-08-31 2003-02-27 Process for the preparation of hydrates of olanzapine and their conversion to crystalline forms of olanzapine

Country Status (12)

Country Link
EP (1) EP1313742A1 (en)
JP (1) JP2004507548A (en)
AU (1) AU2001243475A1 (en)
BR (1) BR0114031A (en)
CA (1) CA2420987A1 (en)
CZ (1) CZ2003566A3 (en)
HU (1) HUP0300875A3 (en)
IL (1) IL154688A0 (en)
NO (1) NO20030926L (en)
RU (1) RU2003108745A (en)
SK (1) SK2502003A3 (en)
WO (1) WO2002018390A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002340328A1 (en) * 2001-10-29 2003-05-12 Janet I. Cord Olanzapine dihydrate-ii a process for its preparation and use thereof
AU2003243153A1 (en) * 2002-04-23 2003-11-10 Dr. Reddy's Laboratories Limited Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
AU2002251329A1 (en) * 2002-04-25 2003-11-10 Generics (Uk) Limited Novel crystalline forms of celecoxib and other compounds
PL196814B1 (en) 2002-05-17 2008-02-29 Inst Farmaceutyczny Method of obtaining polymorphous form of i olansapine
SI1513846T1 (en) 2002-05-31 2011-11-30 Sandoz Ag Process of preparation of olanzapine form i
SI21270A (en) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Crystal forms of olanzapine and procedures for their preparation
PL202856B1 (en) * 2002-12-20 2009-07-31 Adamed Spo & Lstrok Ka Z Ogran Method of obtaining pharmaceutically pure polymorphic form of I olanzapine
EP1575962A1 (en) * 2002-12-24 2005-09-21 Teva Pharmaceutical Industries Limited Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
DE602004014264D1 (en) 2003-12-22 2008-07-17 Teva Pharma PROCESS FOR THE PRODUCTION OF OLANZAPINE
AR047460A1 (en) * 2004-01-27 2006-01-18 Synthon Bv PROCESS FOR THE MANUFACTURE OF 2-METHYL-4- (4-METHYL-1-PIPERAZINYL) ACETATE -10H-TIENO [2,3-B] [1,5] BENZODIAZEPIN (OLANZAPINE ACETATE)
EP1709053B1 (en) 2004-01-27 2011-04-06 Synthon B.V. Stable salts of olanzapine
WO2005080401A1 (en) * 2004-02-19 2005-09-01 Neuland Laboratories Limited Process for the preparation of olanzapine form 1 useful as antipsychotic drug
WO2005107375A2 (en) * 2004-05-06 2005-11-17 Matrix Laboratories Ltd Process for the preparation of olanzapine form-i
DE05783995T1 (en) * 2004-07-14 2007-10-11 Shasun Chemicals and Drugs Ltd., Chennai IMPROVED METHOD FOR THE MANUFACTURE OF FORM I FROM OLANZAPINE
EP1778649A4 (en) 2004-07-14 2008-09-10 Jubilant Organosys Ltd A PROCESS FOR PRODUCING PURE FORM OF 2-METHYL-4-(4-METHYL-1-PIPERAZINYL)-10H-THIENO[2,3-b][1,5]BENZODIAZEPINE
ES2253091B1 (en) 2004-07-27 2007-02-01 Inke, S.A. MIXED SOLVATO OF OLANZAPINE, PROCEDURE FOR OBTAINING AND PROCEDURE OF OBTAINING THE FORM I OF OLANZAPINE FROM THE SAME.
WO2006025065A1 (en) * 2004-08-31 2006-03-09 Lee Pharma Private Limited A process for the preparation of anhydrous olanzopine hydrochloride of form-1
US7829700B2 (en) 2004-09-06 2010-11-09 Shasun Chemicals And Drugs Limited Process for preparation of a pharmaceutically pure polymorphic form I of Olanzapine
SI1838716T1 (en) * 2005-01-05 2011-10-28 Lilly Co Eli Olanzapine pamoate dihydrate
WO2006102176A2 (en) * 2005-03-21 2006-09-28 Dr. Reddy's Laboratories Ltd. Process for preparing crystalline form i of olanzapine
HUP0501046A2 (en) * 2005-11-11 2007-08-28 Egis Gyogyszergyar Nyilvanosan Process for the preparation of olanzapine
US7834176B2 (en) 2006-01-26 2010-11-16 Sandoz Ag Polymorph E of Olanzapine and preparation of anhydrous non-solvated crystalline polymorphic Form I of 2-methyl-4(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine (Olanzapine Form I) from the polymorphic Olanzapine Form E
PL381564A1 (en) 2007-01-22 2008-08-04 Koźluk Tomasz Nobilus Ent The manner of production of basically clean variety of polymorphic olanzapine
EP2185566A2 (en) * 2007-05-15 2010-05-19 Generics Ýuk¨Limited Process for the purification of olanzapine
EP2292624A1 (en) 2009-07-20 2011-03-09 LEK Pharmaceuticals d.d. Process for the purification of olanzapine
CN102093386B (en) * 2011-01-05 2016-06-01 浙江华海药业股份有限公司 A kind of method preparing Zyprexa crystal form II
JP6008734B2 (en) * 2012-12-20 2016-10-19 株式会社トクヤマ Olanzapine type II crystal production method
FI3466934T3 (en) 2016-05-31 2024-04-23 Taiho Pharmaceutical Co Ltd Sulfonamide compounds or salt thereof as ribonucleotide reductase inhibitors for treating cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9009229D0 (en) 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
EG23659A (en) * 1995-03-24 2007-03-26 Lilly Co Eli Process and crystal forms of methyl-thieno-benzodiazepine
ZA978515B (en) * 1996-09-23 1999-03-23 Lilly Co Eli Intermediates and process for preparing olanzapine
AU720366B2 (en) * 1996-09-23 2000-06-01 Eli Lilly And Company Olanzapine dihydrate D

Also Published As

Publication number Publication date
CZ2003566A3 (en) 2004-01-14
WO2002018390A1 (en) 2002-03-07
AU2001243475A1 (en) 2002-03-13
BR0114031A (en) 2003-09-09
HUP0300875A3 (en) 2005-09-28
EP1313742A1 (en) 2003-05-28
CA2420987A1 (en) 2002-03-07
SK2502003A3 (en) 2004-03-02
IL154688A0 (en) 2003-09-17
JP2004507548A (en) 2004-03-11
RU2003108745A (en) 2005-01-10
NO20030926L (en) 2003-04-24
HUP0300875A2 (en) 2003-12-29

Similar Documents

Publication Publication Date Title
NO20030926L (en) Process for the preparation of hydrates of olanzapine and their conversion to crystalline forms of olanzapine
IS6829A (en) New crystalline forms of atorvastatin semi-calcium and methods for their preparation as well as new methods for producing other forms
NO20030012L (en) Process for the preparation of substituted octanoylamides
AU2001255277A1 (en) Use of moving element to produce heat
FI20011578A0 (en) Process for the preparation of pure citalopram
EE200300103A (en) Method of contraception and the form of contraception to be administered
NO20032518D0 (en) Process for the preparation of amlodipine maleate
FI20011622A0 (en) Process for the preparation of citalopram
PT1432685E (en) CRYSTALLINE HYDRATES OF NICOTHINIC ACID AND BENZOYLENYLIDAN ANILIDA DERIVATIVES
NO20024321D0 (en) Process for the preparation of crystalline form I of cabergoline
NO20015316D0 (en) Optimization of fermentation process
AU2001285325A1 (en) Use of threo-methylphenidate compounds to enhance memory
NO20024527D0 (en) Crystalline form II of cabergoline
NO20040368L (en) Process for the preparation and purification of sodium hydride
NO20025423L (en) Process for the preparation of Citalopram
AU1396502A (en) Amorphous form of cell cycle inhibitor
NO20020717L (en) Production of vapor-deposited silica
NO20021118D0 (en) Process for the preparation of citalopram
HUP0101875A3 (en) Process for the preparation of piperidine derivatives
NO20030515L (en) Process for the preparation of dinapsoline
NO20023577L (en) Process for Preparation of Acetyl-Amidinophenylalanyl-Cyclohexylglycyl-Pyridinioalanine Amides
NO20035138D0 (en) Process for the preparation of amorphous sodium silastatin
EA200300327A1 (en) METHOD OF CONVERSION OF ENERGY
NO20032297L (en) Process for the preparation of distamycin derivatives
PL361052A1 (en) Process for preparation of hydrates of olanzapine and their conversion into crystalline forms of olanzapine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application